Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Contributed by: ACCESS Newswire

Logo

Tags

Champions Oncology, Inc.

Healthcare & Pharmaceutical

NASDAQ:CSBR

Company Update

More Like This

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy

AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals

Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung

Transforming Cancer Care: Novotech Releases Report on Radiopharmaceuticals Global Clinical Trials Landscape

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Novotech Maps Global Growth in Radiopharmaceutical Trials